This virus is actually a novel Coronavirus, although there have been two other mutated viruses that have triggered pandemics in the past, one was the SARS which was in 2002 and the other was the MERS which was in 2012. To give you a comparison, the SARS or the “Severe Acute Respiratory Syndrome” had a mortality of 10%. The MERS which is the Middle Eastern respiratory syndrome which came out in 2012 had a mortality as high as 35%. Now the current SARS-CoV-2 has a mortality in 2% to 3% probably more likely 1.5 to 2.5 percent.

One infected person with COVID-19 can transmit it to about 1.5 to 2.5 people whereas in Measles, if one person can get it is likely to infect anywhere from 12 to 18 people and one person can infect another six people in the case of chickenpox which are highly infectious when compared to that the COVID-19 infection.

The common symptoms include fever, body pain and cough which is often observed in other flu’s. Individuals with upper respiratory symptoms are observed that are not commonly associated in COVID-19. Some people have symptoms but no exposure to a proven individual with COVID. Vaccine is most effective against the prevalent form of the virus as it is often very mutable or varies every year based on the infectious form of the flu virus.

Experts advise to wear a mask and stay indoors. Self-quarantine is an effective way if you are not sure about the COVID-19. They also advise to avoid crowds and wash your hands frequently or use a hand sanitizer especially in public places and avoid touching your face with your hands. Civic sense and personal responsibility is paramount at this point if it means Social-isolation.

Diagnostic Pathology: Open Access is collecting manuscripts all over the globe on COVID-19 to endorse the advancement of current knowledge pertaining to clinical studies and scientific investigations and foster discussion in all the relevant aspects of Pathology such as Immunopathology, Virtual Pathology, Tissue based Diagnosis, Immunohistochemistry, Diagnostic Pathology of Infectious Diseases.

We have also announced a Special Issue on this theme acknowledging the significance in the Global Scientific Community. The Special Issue is being edited by our honourable Executive Editorial Chair Person Dr. Maria Teresa Mascellino. The Submissions are Open!

Regards,

Matthew Richard
Diagnostic Pathology: Open Access
WhatsApp: +32-2-808-66-57
E-mail id: diagnospathol@pathologyinsights.org